News

Home
Manufacturing
Manufacturing
OEM Manufacturing
Quality Control
About the Factory
About the Factory
Our History
Management
Certificates
Partners
Licenses
Achievements
Special Evaluation of Labour Conditions
Videos
News
Products
Contacts
Contacts
Quality Claims

News

Details: Published: 29 December 2014

Ural Triazavirin has finally been released. This antiviral drug developed by Sverdlovsk scientists has come pharmacies today. This is such a long-awaited event that the Ural medicine has been sold out briskly.

Details: Published: 22 September 2014

Already this season, the Ural Triazavirin will fight against flu and cold. The antiviral drug produced in Novouralsk will soon appear in Russian pharmacies. The Federal Ministry of Health issued a permission to produce the drug.

Details: Published: 22 September 2014

"The Ministry of Health of the Russian Federation issued a permission to produce the Triazavirin antiviral drug developed in the Urals," said Oleg Chupakhin, Chief Researcher at the Institute of Organic Synthesis, the Ural Branch of the Russian Academy of Sciences, and head of the drug development team.

Details: Published: 10 September 2013

YEKATERINBURG. Bayer, the German corporation, and Medsintez, the Novouralsk plant, have agreed on joint drug manufacturing.

Details: Published: 06 September 2013

On September 9, Medsintez, the Novouralsk plant, will release its first lot of the Aveloks antibiotic. As Alexander Petrov (Jr.), Chairman of Medsintez's Board of Directors, told the EAN agency, the manufacturing of this new-generation drug is carried out according to the agreement signed with the plant's strategic partner, Bayer (Germany).